How Is Drug Resistance Shaping the Bacterial Pneumonia Therapeutics Market?
Bacterial pneumonia remains a leading cause of lower respiratory tract infection mortality globally, characterized by severe pulmonary parenchymal inflammation, alveolar fluid accumulation, and impaired gas exchange. Primarily caused by Streptococcus pneumoniae, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Staphylococcus aureus, effective treatment relies on timely antibiotic...
0 Комментарии 0 Поделились 3 Просмотры 0 предпросмотр